> This makes vaccination very important in high-risk groups, such as elderly, and those with obesity, diabetes or cardiovascular disease.
> The number of adverse cardiac events in young people, especially males, is high. The vaccine seems, in some cases, to be causing heart issues in some men under 29 years old (22-27 myocarditis events per million doses).
> Due to the high COVID-19 survival rate in the under 29-year-old age cohort, it is reasonable to question the risk vs benefit of vaccination.
> vaccines carry risks, and a core concept in medicine is to do no more intervention than is necessary. Without evidence of failed natural immunity after infection, the risks of vaccination may outweigh the benefits.
The OP article was well-written and provided an extremely balanced and accurate interpretation of current scientific consensus. Because the infection fatality rate is extremely low for young healthy adults, and the protection afforded by immunity acquired through previous infection is so effective, the risk-reward calculus changes. I see you've rounded down to "nearly 0 risk", but the fact is the risk is non-zero - that's why the CDC is actively investigating & monitoring the unexpectedly high number of myocarditis cases in in young males, particularly children.
> The only logical response to the data he presents is get vaccinated
As of now the scientific literature has demonstrated that the impact of further vaccination on top of naturally acquired immunity may be marginal and potentially insignificant, especially for young healthy adults. This is relevant to public health policy and vaccination strategy, because we have a limited supply of vaccine doses. It is "logical" to prioritize those doses to people who are immunologically naive, or vulnerable due to age and comorbidities.